Fig. 3
From: Preoperatively predicting early response of HCC to TACE using clinical indicators and MRI features
A 71-year-old male with HCC in the nonresponse group. A, B and C (arterial phase, portal phase and delayed phase), There are one lesion in segment II with a maximum diameter of 3.0 cm had regular margins and another lesion in segment VIII with a maximum diameter of 1.3 cm on preoperative MR imaging. D (Digital subtraction angiography (DSA) before TACE), Proper hepatic artery injection demonstrating one hypervascular tumor located in the left liver (white arrow). E (Digital subtraction angiography (DSA) after TACE), Post-TACE DSA with no tumor blush (white arrow). F, one month after TACE treatment, enhanced tissue on MR imaging indicated the tumor was viable (SD)